These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6380285)

  • 1. Multicenter clinical trial of cefoperazone sodium in the United States.
    Cohen MS; Washton HE; Barranco SF
    Am J Med; 1984 Jul; 77(1B):35-41. PubMed ID: 6380285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Multicenter study of cefoperazone in Austria].
    Forenbacher HH
    Wien Med Wochenschr; 1985 Mar; 135(5):123-6. PubMed ID: 3993050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy and tolerability of cefoperazone in patients with nosocomial infections].
    Albano O; Palasciano G; Morelli N; Monno D; Velardi A; Tardi S; Malvestiti FM
    Clin Ter; 1988 Jul; 126(2):97-100. PubMed ID: 2974382
    [No Abstract]   [Full Text] [Related]  

  • 4. Multicenter clinical trials of cefoperazone in Japan.
    Saito A; Ueda Y
    Clin Ther; 1984; 7(1):49-59. PubMed ID: 6394129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multicentre clinical study on the injection of ceftriaxone/sulbactam compared with cefoperazone/sulbactam in the treatment of respiratory and urinary tract infections.
    Xin X; Jian L; Xia X; Jia B; Huang W; Li C; Wang C; Zhou L; Sun X; Tang X; Huang Y; Zhu Y; Zhang W
    Ann Clin Microbiol Antimicrob; 2013 Dec; 12():38. PubMed ID: 24321187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asian multicenter trial of cefoperazone in respiratory tract infection.
    Matsumoto K; Chung HY; Hsieh WC
    Clin Ther; 1984; 6(6):824-38. PubMed ID: 6391668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Multicenter research on cefoperazone efficacy and tolerance in the therapy of urinary and respiratory infections].
    Paradisi F; de Crescenzo G; Ruffilli MP
    Minerva Med; 1989 Jan; 80(1):43-51. PubMed ID: 2644585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Worldwide clinical experience with cefoperazone.
    Gerber AU; Craig WA
    Drugs; 1981; 22 Suppl 1():108-18. PubMed ID: 6456884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of the efficacy of cefoperazone sodium in the treatment of infections in intensive therapy].
    Fanton G; Spagarino E; Fiorani V; Capellaro L
    Minerva Med; 1987 Nov; 78(21):1621-3. PubMed ID: 3683960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical evaluation of cefoperazone in lower respiratory tract infections].
    Ishibashi T; Takamoto M; Shinoda A; Matsuba K; Yoshida M; Ichikawa Y; Ando M; Matsuzaki Y; Kitahara Y; Hara N
    Jpn J Antibiot; 1986 Oct; 39(10):2780-94. PubMed ID: 3543433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ciprofloxacin: an update on clinical experience.
    Arcieri G; Griffith E; Gruenwaldt G; Heyd A; O'Brien B; Becker N; August R
    Am J Med; 1987 Apr; 82(4A):381-6. PubMed ID: 3555063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aztreonam: worldwide overview of the treatment of patients with gram-negative infections.
    Henry SA; Bendush CB
    Am J Med; 1985 Feb; 78(2A):57-64. PubMed ID: 3881950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sulbactam/cefoperazone versus cefotaxime for the treatment of moderate-to-severe bacterial infections: results of a randomized, controlled clinical trial.
    Li JT; Lu Y; Hou J; Chen YF; Miao JZ; Jia YX; Hou J; Zhang XZ; Chen DK; Hu WZ; Li LJ; Liu DM; Wang Z; Wu J; Gu JM; Wang HL; Zhang YL; Sun L
    Clin Infect Dis; 1997 Mar; 24(3):498-505. PubMed ID: 9114206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cefoperazone sodium in the treatment of serious bacterial infections in 2,100 adults and children: multicentered trials in Europe, Latin America, and Australasia.
    Gordon AJ; Phyfferoen M
    Rev Infect Dis; 1983; 5 Suppl 1():S188-99. PubMed ID: 6221390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlled trials of double beta-lactam therapy with cefoperazone plus piperacillin in febrile granulocytopenic patients.
    Winston DJ; Ho WG; Bruckner DA; Gale RP; Champlin RE
    Am J Med; 1988 Jul; 85(1A):21-30. PubMed ID: 3041815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative in-vitro activity of cefoperazone-tazobactam and cefoperazone-sulbactam combinations against ESBL pathogens in respiratory and urinary infections.
    Patankar M; Sukumaran S; Chhibba A; Nayak U; Sequeira L
    J Assoc Physicians India; 2012 Nov; 60():22-4. PubMed ID: 23767198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical evaluation of sulbactam/cefoperazone in lower respiratory tract infections].
    Ishibashi T; Takamoto M; Shinoda A; Yoshida M; Ichikawa Y; Kido M; Ninomiya K; Kitahara Y; Hara N; Tsurutani H
    Jpn J Antibiot; 1990 Feb; 43(2):239-56. PubMed ID: 2194054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of cefoperazone in clinical practice].
    Strachunskiĭ LS; Prokhorenkov PI; Novikova IuA; Krechikova OI; Iakusheva LV
    Antibiot Khimioter; 1992 Aug; 37(8):19-21. PubMed ID: 1456817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Moxalactam: clinical summary of efficacy and safety.
    Kammer RB
    Rev Infect Dis; 1982; 4 Suppl():S712-9. PubMed ID: 6218589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical trials with cefoperazone in the field of surgery in Japan.
    Shibata K
    Clin Ther; 1980; 3(Spec Issue):173-89. PubMed ID: 6446393
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.